Resetting Target Figures under the Challenge Plan
First written in FY2020. 2 of 3 entries say "Softened", first in FY2020. Latest entry: FY2022.
Artnature moved to the "Worse" side of this theme in 2022, 1 year after the typical company in this theme (2021).
The whole theme swung hardest in 2020: 10 of 32 companies on the "Worse" side.
4 other companies' latest entry also says "Softened".
- FY2022SoftenedAnnual report
「Management indicators Fiscal year ended March 2022 (actual) Fiscal year ending March 2023 (target) Net sales ¥40,437 million ¥41,991 million Ordinary profit margin on net sales 7.5% 5.1% ROE 4.9% 4.7%」
The Company disclosed its targets for the fiscal year ending March 2023, but lowered them from the previously disclosed figures of net sales of ¥44,098 million, an ordinary profit margin on net sales of 8.5%, and ROE of 9.1% to ¥41,991 million, 5.1%, and 4.7%, respectively. - FY2021Disclosure of target figuresAnnual report
「Management indicators Fiscal year ended March 2021 (actual) Fiscal year ending March 2023 (target) Net sales ¥35,868 million ¥44,098 million Ordinary profit margin on net sales 5.6% 8.5% ROE 3.3% 9.1%」
The Company disclosed the Challenge Plan targets for the fiscal year ending March 2023, which had remained undecided in the previous fiscal year because of uncertainty surrounding the impact of COVID-19: net sales of ¥44,098 million, an ordinary profit margin on net sales of 8.5%, and ROE of 9.1%. - FY2020SoftenedAnnual report
「The management indicators targeted under the Art Nature Challenge Plan are as follows. As many factors remain uncertain regarding the impact of the global spread of COVID-19 on domestic and overseas economies and the Company's performance, the target management indicators are currently undecided and will be disclosed promptly once reasonable forecasts become possible.」
The previous medium-term plan specified targets for net sales, ordinary profit margin on net sales and ROE, but the new plan left the targets for the fiscal year ending March 2023 undecided because the impact of the spread of COVID-19 remained uncertain.